TMDX

OrthoPediatrics Corp. (KIDS) has launched its Enabling Technologies division, which will leverage the company's core mission of addressing unmet pediatric needs in orthopedics. The new division is expected to differentiate KIDS' core business, generate sustainable revenue growth, and gain access to ...

Paragon 28 has launched a new Right-Angle Drill for its APEX 3D Total Ankle Replacement System, which is expected to improve the long-term success of ankle replacements. The company's stock gained 3.1% following the launch.

TransMedics, a leader in organ transplant technologies, has seen its stock price experience wild volatility due to its revolutionary Organ Care System, high sales growth, and newfound profitability. Despite the company's first-mover advantage, its valuation remains high, requiring a long-term invest...

TransMedics (TMDX) has seen a significant improvement in its earnings outlook, with analysts raising their estimates for the company. This positive trend in earnings estimate revisions is driving the stock's performance and could continue to push it higher.

TransMedics reported strong Q2 2024 earnings, with revenue up 117.9% year-over-year and EPS of $0.35 compared to -$0.03 in the prior year. The company's performance exceeded analyst estimates across key metrics like geographic revenues and net revenue by product line.